ADA Diabetes Journal Symposium—Staying in Network—Adipocyte Communication in Regulation of Energy Balance
Sunday, June 25, at 8:00 a.m. PT
San Diego Convention Center
Presentation: Adipsin and Beta-Cell Function
James Lo, MD, PhD
Weill Cornell Medicine
What is your presentation about?
Some people with type 2 diabetes develop beta cell failure where they need to get insulin injections or other medications that increase insulin secretion. Our research looks into inputs from outside and within the pancreas might affect progression to beta cell failure. For example, we identify beneficial signals coming from fat tissues that help beta cells.
What makes this topic important in 2023?
We now have more sophisticated tools to answer what causes beta cell failure and how interorgan communication works in 2023 than ever before. These are exciting scientific times colliding with the ongoing diabetes epidemic.
How did you become involved with this area of diabetes research or care?
I am a cardiologist and see many patients with diabetes and concomitant heart disease. This is a major epidemic and one we need to get a handle on quickly before things get worse.
How do you think your presentation will impact diabetes research or care?
Our research findings inform on why beta cells could malfunction in people with type 2 diabetes. This could influence future therapies that limit beta cell loss that could prevent type 2 diabetes and/or its complications.
What are you most looking forward to at the 83rd Scientific Sessions?
Reconnecting with and meeting new colleagues working on the common goal of reducing metabolic diseases like diabetes and its complications.
Register to View the 83rd Scientific Sessions Virtual Program
Virtual registration is still an option to take advantage of the valuable content presented at the 83rd Scientific Sessions on the latest advances in diabetes research, prevention, and care. Access to the virtual program is available to registered participants June 27–August 28.